Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy
Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.
Feb 28, 2024
0
15